These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20858837)

  • 1. Hypoxia in models of lung cancer: implications for targeted therapeutics.
    Graves EE; Vilalta M; Cecic IK; Erler JT; Tran PT; Felsher D; Sayles L; Sweet-Cordero A; Le QT; Giaccia AJ
    Clin Cancer Res; 2010 Oct; 16(19):4843-52. PubMed ID: 20858837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologically increased tumor hypoxia can be measured by 18F-Fluoroazomycin arabinoside positron emission tomography and enhances tumor response to hypoxic cytotoxin PR-104.
    Cairns RA; Bennewith KL; Graves EE; Giaccia AJ; Chang DT; Denko NC
    Clin Cancer Res; 2009 Dec; 15(23):7170-4. PubMed ID: 19920111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
    Huang T; Civelek AC; Li J; Jiang H; Ng CK; Postel GC; Shen B; Li XF
    J Nucl Med; 2012 Aug; 53(8):1262-8. PubMed ID: 22717978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice.
    Yu L; Hales CA
    BMC Cancer; 2011 Aug; 11():331. PubMed ID: 21812995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice.
    He XY; Chen JX; Zhang Z; Li CL; Peng QL; Peng HM
    J Cancer Res Clin Oncol; 2010 Jul; 136(7):1023-8. PubMed ID: 20033209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging.
    Solomon B; Binns D; Roselt P; Weibe LI; McArthur GA; Cullinane C; Hicks RJ
    Mol Cancer Ther; 2005 Sep; 4(9):1417-22. PubMed ID: 16170034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.
    Jacoby JJ; Erez B; Korshunova MV; Williams RR; Furutani K; Takahashi O; Kirkpatrick L; Lippman SM; Powis G; O'Reilly MS; Herbst RS
    J Thorac Oncol; 2010 Jul; 5(7):940-9. PubMed ID: 20512076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Carbogen Breathing on
    Lin Y; Bao YN; Huang CX; Zhang JH; Yu ZL; Tian Y; Wang XC; Cui YT
    Biomed Res Int; 2019; 2019():2920169. PubMed ID: 31886195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.
    Busk M; Horsman MR; Jakobsen S; Keiding S; van der Kogel AJ; Bussink J; Overgaard J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1202-12. PubMed ID: 18313528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study.
    Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF
    J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of hypoxic PET using (18)F-FAZA and (62)Cu-ATSM in non-small-cell lung cancer.
    Kinoshita T; Fujii H; Hayashi Y; Kamiyama I; Ohtsuka T; Asamura H
    Lung Cancer; 2016 Jan; 91():56-66. PubMed ID: 26711935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.
    Bollineni VR; Kerner GS; Pruim J; Steenbakkers RJ; Wiegman EM; Koole MJ; de Groot EH; Willemsen AT; Luurtsema G; Widder J; Groen HJ; Langendijk JA
    J Nucl Med; 2013 Aug; 54(8):1175-80. PubMed ID: 23753185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-fluoromisonidazole PET reveals spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer.
    Cui YL; Wang X; Li XF
    Future Oncol; 2015; 11(20):2841-9. PubMed ID: 26361064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model.
    Büchler P; Reber HA; Lavey RS; Tomlinson J; Büchler MW; Friess H; Hines OJ
    J Surg Res; 2004 Aug; 120(2):295-303. PubMed ID: 15234226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K‑ras gene mutation as a predictor of cancer cell responsiveness to metformin.
    Ma Y; Guo FC; Wang W; Shi HS; Li D; Wang YS
    Mol Med Rep; 2013 Sep; 8(3):763-8. PubMed ID: 23877793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model.
    Ermolayev V; Mohajerani P; Ale A; Sarantopoulos A; Aichler M; Kayser G; Walch A; Ntziachristos V
    Int J Cancer; 2015 Sep; 137(5):1107-18. PubMed ID: 25450481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study.
    Mortensen LS; Busk M; Nordsmark M; Jakobsen S; Theil J; Overgaard J; Horsman MR
    Radiother Oncol; 2011 Jun; 99(3):418-23. PubMed ID: 21723634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time Tumor Oxygenation Changes After Single High-dose Radiation Therapy in Orthotopic and Subcutaneous Lung Cancer in Mice: Clinical Implication for Stereotactic Ablative Radiation Therapy Schedule Optimization.
    Song C; Hong BJ; Bok S; Lee CJ; Kim YE; Jeon SR; Wu HG; Lee YS; Cheon GJ; Paeng JC; Carlson DJ; Kim HJ; Ahn GO
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):1022-1031. PubMed ID: 27130790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location.
    Vilalta M; Hughes NP; Von Eyben R; Giaccia AJ; Graves EE
    Mol Imaging Biol; 2017 Apr; 19(2):215-224. PubMed ID: 27709411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P7170, a novel inhibitor of mTORC1/mTORC2 and Activin receptor-like Kinase 1 (ALK1) inhibits the growth of non small cell lung cancer.
    Venkatesha VA; Joshi A; Venkataraman M; Sonawane V; Bhatia D; Tannu P; Bose J; Choudhari S; Srivastava A; Pandey PK; Lad VJ; Sangana R; Ahmed T; Damre A; Deore V; Sahu B; Kumar S; Sharma S; Agarwal VR
    Mol Cancer; 2014 Dec; 13():259. PubMed ID: 25466244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.